ChemoCentryx Inc.

NASDAQ: CCXI · Real-Time Price · USD
51.99
0.05 (0.10%)
At close: Oct 19, 2022, 10:00 PM

ChemoCentryx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
32.22M
Cost of Revenue
302K
Gross Profit
31.92M
Operating Income
-134.45M
Interest Income
859K
Pretax Income
-131.75M
Net Income
-129.06M
Selling & General & Admin
78.85M
Research & Development
82.99M
Other Expenses
302K
Operating Expenses
162.14M
Interest Expense
-2.69M
Selling & Marketing Expenses
n/a
Cost & Expenses
162.44M
Income Tax Expense
-2.69M
Shares Outstanding (Basic)
65.69M
Shares Outstanding (Diluted)
65.69M
EPS (Basic)
-1.96
EPS (Diluted)
-1.96
EBITDA
-131.31M
EBIT
-134.45M
Depreciation & Amortization
3.14M